TABLE 2.
Biological functions of BglF individual domains or combinations of domains in vivo
| Plasmid(s) | Plasmid-encoded BglF derivative | Complementationa of bglF mutant strain PPA501 (expressing IIAglc and EIInag) | β-Galactosidase activity (U)b
|
|
|---|---|---|---|---|
| Without salicin | With salicin | |||
| pMN5 | Wild-type BglF | + | 5 | 153 |
| pACQ-F3 | IIBbgl | − | 3 | 5 |
| pT7CQ-F4 | IICbgl | − | 175 | 178 |
| pT7CQ-F5 | IIAbgl | − | 225 | 255 |
| pACQ-F6 | IICAbgl | − | 724 | 637 |
| pACQ-F8 | IIBCbgl | + | 10 | 415 |
| pACQ-F6/ pT7CQ-F3 | IICAbgl + IIBbgl | − | 5 | 5 |
| pT7CQ-F4/ pACQ-F3 | IICbgl + IIBbgl | − | 4 | 4 |
| pBR322 | − | 447 | 456 | |
Complementation was indicated by two alternative methods: +, growth on minimal arbutin plates and red colonies on MacConkey arbutin plates; −, no growth on minimal arbutin plates and white colonies on MacConkey arbutin plates.
Determined with strain PPA501, which carries a bgl-lacZ transcriptional fusion and a defective bglF gene and which constitutively expresses IIAglc and EIInag, encoded by genes crr and nagE, respectively. The values represent the averages of four independent measurements. Salicin at 7 mM was added to the growth medium when indicated.